Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is February - January.

Millions CAD. Fiscal year is Feb - Jan.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	Aug '25 Aug 8, 2025	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021	2017 - 2021
Market Capitalization	6	2	1	2	4	5	Upgrade
Market Cap Growth	63.24%	8.82%	-28.57%	-46.15%	-21.80%	33.71%	Upgrade
Enterprise Value	6	2	1	2	3	4	Upgrade
Last Close Price	0.07	0.03	0.03	0.04	0.07	0.12	Upgrade
PB Ratio	2.03	0.52	0.47	0.61	1.06	2.13	Upgrade
P/TBV Ratio	2.03	0.52	0.47	0.61	1.06	2.13	Upgrade
EV/EBITDA Ratio	-	-	-	-	13.10	-	Upgrade
Debt / Equity Ratio	0.02	0.02	-	-	-	-	Upgrade
Quick Ratio	0.03	0.20	0.05	1.81	2.82	0.35	Upgrade
Current Ratio	0.03	0.20	0.07	1.89	3.06	0.40	Upgrade
Return on Equity (ROE)	-7.95%	-6.37%	-7.02%	-6.51%	-19.41%	-57.63%	Upgrade
Return on Assets (ROA)	-4.11%	-3.31%	-3.82%	-4.71%	-10.53%	-31.02%	Upgrade
Return on Capital (ROIC)	-4.44%	-3.53%	-3.97%	-4.96%	-11.49%	-33.01%	Upgrade
Earnings Yield	-3.98%	-12.46%	-15.62%	-11.07%	-15.00%	-29.18%	Upgrade
FCF Yield	-3.44%	-9.97%	-10.35%	-30.47%	-31.11%	-20.08%	Upgrade
Buyback Yield / Dilution	-8.54%	-6.33%	-	-4.40%	-52.54%	-54.47%	Upgrade

Updated Dec 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.